Introduction
Ireland has announced a major healthcare contract award, with the Health Service Executive (HSE) confirming the award of a national contract for the provision and support of a Home Peritoneal Dialysis (PD) service. Valued at an estimated €82.12 million, the services contract has been awarded to Vantive Health Limited and will support patients across multiple HSE regions. The contract was signed on 14 October 2025 and published as a Contract Award Notice in November 2025.
Contract Details
The awarded contract covers the delivery of a comprehensive home peritoneal dialysis service, including the supply of medical equipment, consumables, and ongoing clinical and technical support services. The contract supports the National Peritoneal Dialysis Programme across HSE South, HSE West, HSE Dublin North-East, and HSE Dublin Mid-Leinster, ensuring nationwide service availability.
Classified as a services contract, the procurement is associated with CPV codes 85110000, 85140000, 33181000, and 33181520, covering health services, medical support services, and dialysis-related medical devices. The estimated contract value of €82,121,960 highlights the long-term and strategic nature of the programme within Ireland’s public healthcare system.
Entities Involved
The procuring authority is the Health Service Executive (HSE), Ireland’s national public health body, headquartered in County Kildare. The HSE is responsible for delivering health and social care services nationwide.
The successful provider, Vantive Health Limited, is based in Dublin and operates as a specialist healthcare company delivering renal care solutions, including home-based dialysis services. Details of other bidders were not disclosed in the Contract Award Notice.
Clinical and Strategic Significance
This government healthcare contract award represents a significant investment in home-based renal care, supporting patient-centred treatment models that reduce hospital dependency and improve quality of life for individuals with chronic kidney disease. Home peritoneal dialysis allows patients to receive treatment in their own homes while maintaining clinical oversight and support.
From a system perspective, the contract supports the HSE’s strategic objectives around care delivery closer to home, improved capacity management in acute hospitals, and long-term cost efficiency within renal services.
Background on the Winning Company
Vantive Health Limited specialises in renal therapies and patient support services, with experience in delivering integrated dialysis solutions that combine equipment provision, consumables logistics, and clinical support. The company’s appointment reflects its capability to manage complex, nationwide healthcare service contracts.
Technical and Financial Overview
While detailed clinical protocols were not published, the contract scope includes dialysis equipment provision, regular supply of consumables, patient training, technical maintenance, and ongoing support services. The €82.12 million estimated value suggests a multi-year national framework, supporting consistent service standards across all HSE regions.
Conclusion
The award of the National Home Peritoneal Dialysis Service contract to Vantive Health marks a key milestone in Ireland’s renal care strategy. As implementation progresses, the contract is expected to enhance patient outcomes, expand access to home-based treatment, and strengthen the sustainability of dialysis services nationwide. The award also highlights the scale and importance of awarded tenders within Ireland’s public healthcare procurement landscape.
#IrelandHealthcareContracts #HSEProcurement #HomeDialysisIreland #PeritonealDialysisService #RenalCareIreland #GovernmentContractsIreland #ContractAward #TenderResults #AwardedTenders #PublicHealthcareProcurement #ProcurementNewsIreland
